Aislinn Antrim, Associate Editorial Director

The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.

The approval makes remdesivir the first and only approved antiviral treatment for patients across all stages of renal disease.

Express Scripts recently announced the addition of 3 Humira biosimilars to its main formulary.

The approval of norgestrel tablets (Opill) could open the door to other prescription-to-OTC contraceptive switches, although that remains to be seen as other pharmaceutical companies weigh their options.

Study shows equivalent overall survival among younger adults with acute lymphoblastic leukemia aged 15 to 29 and older adults aged 30 to 50 with normal BMI.

Using artificial intelligence to sort and respond to patient queries could streamline processes and alleviate provider burnout.

The study also found significant evidence of outcomes disparities between minority populations and White populations.

Less than half of respondents would recommend a vaccine against respiratory syncytial virus to a pregnant friend or family member.

Body mass index fails to account for differences in race, ethnicity, age, sex, and other factors, and has a history of use for racist exclusion.

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

Clinical trial results showed that the combination significantly improved radiographic progression-free survival compared with enzalutamide monotherapy for homologous recombination repair gene–mutated metastatic castration-resistant prostate cancer.

A plethora of targeted therapies, biomarker-driven therapies, and immunotherapies are now available.

The meeting aims to bring together pharmacists to discuss solutions for responding to the rapidly evolving evidence and needs for effective implementation.

Having more severe sleep apneas was associated with having lower brain volume in the medial temporal lobe area of the brain, which could suggest loss of brain cells.

The combination also reduced the risk of developing distant metastasis or death by 65% in patients with high-risk stage 3/4 melanoma.

The proportion of participants with cytomegalovirus disease was 10% with letermovir and 12% with valganciclovir.

Findings highlight the potential efficacy of combining 2 novel bispecific therapies, teclistamab-cqyv and talquetamab, which target distinct antigens on myeloma cells.

Treatment with Injectafer significantly improved exercise capacity compared to placebo in a randomized clinical trial in adult patients with heart failure.

Findings presented at the American Society of Clinical Oncology (ASCO) 2023 meeting show the long-term efficacy and safety profile of larotrectinib (Vitrakvi; Bayer) in solid tumors with NTRK gene fusion.

Investigators previously reported a statistically significant improvement in radiographic progression-free survival in the full intention-to-treat population of adults with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.

Structural inequalities that contribute to HIV acquisition are known to also contribute to housing stability, and this was apparent in findings regarding race and ethnicity.

The preventive effect is believed to be a result of compounds unique to cranberries called proanthocyanidins.

The risk of long COVID-19 in females in the least deprived areas was comparable to the risk of males in the most deprived areas.

Supportive nurse managers and supervisors as well as nurses’ involvement in organizational governance may help lower hospital-onset Clostridioides difficile infection in acute care hospitals.

Findings suggest that mice derived from and breastfed by immunized mothers were capable of producing anti- pneumococcal surface protein A (PspA) specific antibodies, despite having no direct exposure to PspA.

Treatment with epcoritamab-bysp showed a 61% overall response rate and a 38% complete response rate in heavily pretreated patients with R/R DLBCL.

The approval marks the first and only FDA-approved treatment for dry eye disease that directly targets tear evaporation.

Nanoparticles could improve the solubility of drugs, aid in treatment escape from the immune system, and increase the half-life of drugs in the circulatory system against viral lung infections such as influenza, coronavirus, and respiratory syncytial virus.

PCV10 protection is likely to have reduced the incidence of pneumococcal disease among all ages by between 48% and 66%.

Treatment-emergent adverse events were reported in a similar proportion of participants with recurrent Clostridioides difficile infection, both with and without immunocompromising conditions.